128 related articles for article (PubMed ID: 7677916)
21. Radiotherapy of Graves' ophthalmopathy.
Sautter-Bihl ML; Heinze HG
Dev Ophthalmol; 1989; 20():139-54. PubMed ID: 2687049
[No Abstract] [Full Text] [Related]
22. Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay.
Ahmann A; Baker JR; Weetman AP; Wartofsky L; Nutman TB; Burman KD
J Clin Endocrinol Metab; 1987 Mar; 64(3):454-60. PubMed ID: 2434519
[TBL] [Abstract][Full Text] [Related]
23. Radiation retinopathy after standard radiotherapy for thyroid-related ophthalmopathy.
Miller ML; Goldberg SH; Bullock JD
Am J Ophthalmol; 1991 Nov; 112(5):600-1. PubMed ID: 1951605
[No Abstract] [Full Text] [Related]
24. Ocular complications of high-dose radiotherapy.
Brady LW
Oncology (Williston Park); 1996 Jul; 10(7):981-2, 984. PubMed ID: 8837116
[TBL] [Abstract][Full Text] [Related]
25. Letter: Orbital radiation in Graves' disease.
Rubenzik R
Am J Ophthalmol; 1975 May; 79(5):888-9. PubMed ID: 1173740
[No Abstract] [Full Text] [Related]
26. Graves' ophthalmopathy: current concepts regarding pathogenesis and management.
Burch HB; Wartofsky L
Endocr Rev; 1993 Dec; 14(6):747-93. PubMed ID: 8119236
[TBL] [Abstract][Full Text] [Related]
27. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy.
Prummel MF; Terwee CB; Gerding MN; Baldeschi L; Mourits MP; Blank L; Dekker FW; Wiersinga WM
J Clin Endocrinol Metab; 2004 Jan; 89(1):15-20. PubMed ID: 14715820
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic controversies. Retrobulbar radiation in Graves' ophthalmopathy.
Wiersinga W; Prummel MF
J Clin Endocrinol Metab; 1995 Feb; 80(2):345-7. PubMed ID: 7852487
[No Abstract] [Full Text] [Related]
29. [Severe injury of the eye and orbit after radiotherapy].
Merklová G; Molitorisová M; Novotný L
Cesk Oftalmol; 1980 Sep; 36(5):341-3. PubMed ID: 7418043
[No Abstract] [Full Text] [Related]
30. The incidence of ophthalmopathy after radioiodine therapy for Graves' disease: prognostic factors and the role of methimazole.
Kung AW; Yau CC; Cheng A
J Clin Endocrinol Metab; 1994 Aug; 79(2):542-6. PubMed ID: 7913934
[TBL] [Abstract][Full Text] [Related]
31. [Radiotherapy of Graves' ophthalmopathy--state of the art and review of the literature].
Eich HT; Micke O; Seegenschmiedt MH
Rontgenpraxis; 2007; 56(4):137-44. PubMed ID: 17390953
[TBL] [Abstract][Full Text] [Related]
32. Complications and late changes following radiation therapy for carcinoma of the eyelid and canthi.
Levitt SH; Bogardus CR; Brandt EN
Radiology; 1966 Aug; 87(2):340-7. PubMed ID: 5915441
[No Abstract] [Full Text] [Related]
33. [Prevalence of eye diseases in Basedow disease. Apropos of a prospective study with 85 cases].
Vangheluwe O; Ducasse A; Vaudrey C; Maes B; Delisle MJ; Segal A
J Fr Ophtalmol; 1992; 15(8-9):469-73. PubMed ID: 1294610
[TBL] [Abstract][Full Text] [Related]
34. Orbital irradiation in the treatment of Graves' ophthalmopathy.
Bartalena L; Marcocci C; Panicucci M; Bogazzi F; Pinchera A
Bull Soc Belge Ophtalmol; 1988; 226():71-83. PubMed ID: 3151769
[No Abstract] [Full Text] [Related]
35. Airway complication occurring during radioiodine treatment for Graves' disease.
Kinuya S; Yoneyama T; Michigishi T
Ann Nucl Med; 2007 Aug; 21(6):367-9. PubMed ID: 17705018
[TBL] [Abstract][Full Text] [Related]
36. Retinopathy after irradiation for Graves' ophthalmopathy.
Nikoskelainen E; Joensuu M
Lancet; 1989 Sep; 2(8664):690-1. PubMed ID: 2570949
[No Abstract] [Full Text] [Related]
37. [Treatment of Graves' ophthalmopathy with irradiation].
Slampa P; Spurný V; Seneklová Z; Krákorová D
Vnitr Lek; 1998 Aug; 44(8):461-3. PubMed ID: 10358449
[TBL] [Abstract][Full Text] [Related]
38. Probable risk of tumor induction after retro-orbital irradiation for Graves' ophthalmopathy.
Blank LE; Barendsen GW; Prummel MF; Stalpers L; Wiersinga W; Koornneel L
Radiother Oncol; 1996 Aug; 40(2):187-9. PubMed ID: 8884975
[No Abstract] [Full Text] [Related]
39. Classification of Graves' ophthalmopathy.
Feldon S
Thyroid; 1993; 3(2):171. PubMed ID: 8369655
[No Abstract] [Full Text] [Related]
40. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
